The contract worth over $1 million with an NIH-funded researcher is a significant achievement for Scorpius Holdings, indicating potential for increased revenue and improved market standing. Given the size of the contract and the involvement of NIH funding, it's reasonable to expect a positive short-term impact on SCPX's stock price due to increased investor confidence and potential future growth prospects.